Patient characteristics | all | <65 years | ≥ 65 years |
---|---|---|---|
Number of Patients | 88 | 73 | 15 |
Median age (range), years | 56 (32–78) | ||
n (%) | |||
Gender | |||
Female | 31 (35.2) | 29 (39.7) | 2 (13.3) |
Male | 57 (64.8) | 44 (60.3) | 13 (86.7) |
ECOG PS | |||
0 | 49 (55.7) | 43 (58.9) | 6 (40.0) |
1 | 36 (40.9) | 27 (37.0) | 9 (60.0) |
2 | 3 (3.4) | 3 (4.1) | 0 |
Metastatic disease | 79 (89.8) | 64 (87.7) | 15 (100.0) |
Locally advanced tumor | 9 (10.2) | 9 (12.3) | 0 |
Primary palliative treatment | 66 (75.0) | 55 (75.3) | 11 (73.3) |
Previous resection | 22 (25.0) | 18 (24.7) | 4 (26.7) |
Prior (neo-) adjuvant CTX | 13 (14.8) | 11 (15.1) | 2 (13.3) |
Site of Tumor | |||
Pancreatic head | 50 (56.8) | 42 (57.5) | 8 (53.3) |
Pancreatic corpus | 22 (25.0) | 20 (27.4) | 2 (13.3) |
Pancreatic tail | 16 (18.2) | 11 (15.1) | 5 (33.3) |